The Role of PET Imaging in Gynecologic Radiation Oncology

Yuan James Rao, Perry W. Grigsby

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


The goal of this review is to discuss the current utility of fluorine-18–fluorodeoxyglucose (FDG)–PET for radiation oncologists who treat gynecologic malignancies. FDG-PET/computed tomography (CT) is recommended for baseline assessment in cervical cancer and for staging in vulvar and vaginal cancer. The authors use FDG-PET/CT in definitive radiation treatment planning for cervical, vulvar, and vaginal cancer. PET may be helpful for salvage radiation treatment planning for any recurrent gynecologic malignancy. There are published data to support the use of PET in posttreatment evaluation of cervical and vulvar cancer.

Original languageEnglish
Pages (from-to)225-237
Number of pages13
JournalPET Clinics
Issue number2
StatePublished - Apr 2018


  • Cervical cancer
  • Gynecologic oncology
  • Ovarian cancer
  • PET
  • Radiation therapy
  • Uterine cancer
  • Vulvar cancer


Dive into the research topics of 'The Role of PET Imaging in Gynecologic Radiation Oncology'. Together they form a unique fingerprint.

Cite this